Dhaka University IBA and Beximco Pharma Sign MoU for Executive Training
The Institute of Business Administration (IBA) at Dhaka University and Beximco Pharmaceuticals PLC have signed a Memorandum of Understanding (MoU) to conduct an executive training program titled 'Advanced Certificate in Pharmaceutical Business Administration (ACPBA)'. The signing ceremony took place on Tuesday, with Professor Abu Yusuf Md. Abdullah, Director of DU's IBA, and Rabbur Reza, Chief Operating Officer of Beximco Pharmaceuticals PLC, signing on behalf of their respective institutions. The event was attended by key figures including Professor Md. Mohiuddin, Moderator of the ACPBA program at IBA; Professor Abu Yusuf Md. Abdullah; Rabbur Reza; and MA Arshad Bhuiyan, Executive Director and Head of HR at Beximco Pharmaceuticals PLC. Speakers emphasized the importance of strengthening collaboration between industry and educational institutions, expressing optimism that this initiative will significantly contribute to developing skilled human resources for Bangladesh's pharmaceutical sector. The IBA will deliver the ACPBA training program under this MoU, aiming to enhance the business administration, leadership, management, and pharmaceutical business knowledge and skills of working professionals in the pharmaceutical industry. The program is designed to align professional capabilities with the demands of the sector. Each training batch will span approximately six months, comprising 40 sessions totaling around 120 hours. Over a two-year period, a total of four batches are planned, with each batch accommodating a maximum of 40 to 45 participants. The training will be led by IBA faculty members and experienced senior executives from the industry as resource persons, utilizing methods such as lectures, case studies, group exercises, workshops, and presentations. Participants successfully completing the course will receive a certificate from IBA, Dhaka University.
This collaboration between Dhaka University's IBA and Beximco Pharmaceuticals PLC highlights a strategic move to bridge the gap between academic knowledge and industry-specific needs in the pharmaceutical sector. By focusing on advanced business administration and leadership within a specialized context, the program aims to cultivate a more adept workforce. The structure, involving experienced faculty and industry professionals, suggests an effort to deliver practical, up-to-date insights. Looking ahead, such partnerships are crucial for fostering innovation and competitiveness in a rapidly evolving global market, particularly as advancements in AI and biotechnology reshape pharmaceutical business models. Ensuring the curriculum remains agile to incorporate these future trends will be key to the program's long-term relevance and impact on the industry's human capital development.
AI-generated to prompt reflection — not editorial opinion, not advice, not a statement of fact. How this works.